Smartwatches in Clinical Research: A Valuable Opportunity
In this IMMEDIATE insight, Giulia Vismara, a Scientific Content Manager at Zadig srl writes about the opportunity smartwatches offer in clinical r...
The EU-funded research project IMMEDIATE strives to identify individual biomarkers of risk and resilience against chronic inflammation by investigating the diet-microbiome-metabolite-immune axis. This complex interaction refers to how an individual's diet, gut microbiota, metabolites, and immune system can influence their health.
IMMEDIATE will use cutting-edge technologies and clinical and metadata from large observational cohort studies to identify pre-disease stages and further our understanding of the mechanisms and molecular pathways underpinning non-communicable diseases. Furthermore, a proof-of-concept study on healthcare professionals will be conducted to test the effectiveness of a probiotic intervention and ultimately develop mobile apps designed to offer personalized lifestyle recommendations and empower citizens to manage their own health proactively.
Professor Dr med Friedemann Paul
Charité – Universitätsmedizin Berlin
As society and the environment change, we need novel prevention strategies for staying healthy. By expanding the overall understanding of chronic inflammation and health-to-disease transitions, we strive to provide citizens with personalised health guidance and innovative technological tools to reduce their risk of developing chronic diseases
IMMEDIATE and the SDGs: Climate change impacts on health
In this IMMEDIATE insight, Dr Sonja Bergner, an expert in sustainable innovation at EURICE, shares insights into how following a cross-cutting One...